Commentary: Oncologic Drugs in Patients with Organ Dysfunction: A Summary
Authors:
- 1 September 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 12 (9) , 1070-1083
Abstract
Learning Objectives: After completing this course, the reader will be able to: Describe the currently recommended dose adjustments for common chemotherapeutics in oncology patients with organ dysfunction.Explain the rationale for using phase I dose-escalation studies to determine appropriate chemotherapy dosing in patients with organ dysfunction.Discuss the limitations of the currently available studies to guide chemotherapy dose adjustment in patients with organ dysfunction. Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.comKeywords
This publication has 50 references indexed in Scilit:
- Liver metastases from breast cancer: management of patients with significant liver dysfunctionCancer Treatment Reviews, 2004
- Therapeutic Options in Patients With Lymphoma and Severe Liver DysfunctionMayo Clinic Proceedings, 2004
- Epirubicin in patients with liver dysfunctionEuropean Journal of Cancer, 2003
- Treatment of the jaundiced patient with breast carcinomaCancer, 2001
- Pharmacokinetics of anticancer agents in patients with impaired liver functionEuropean Journal of Cancer, 1998
- Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry testsBritish Journal of Cancer, 1992
- Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover studyCancer Chemotherapy and Pharmacology, 1992
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- Acute doxorubicin toxicity relationship to pretreatment liver function, response, and pharmacokinetics in patients with acute nonlymphocytic leukemiaCancer, 1984
- Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high-dosage scheduleCancer, 1974